US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 906.540
  • -0.780-0.09%
Close Apr 24 16:00 ET
  • 908.320
  • +1.780+0.20%
Post 16:23 ET
99.50BMarket Cap26.07P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
7.76%13.12B
0.58%3.43B
14.53%3.36B
10.53%3.16B
6.64%3.16B
-24.26%12.17B
-31.05%3.41B
-14.96%2.94B
-44.40%2.86B
17.26%2.97B
Operating revenue
6.55%12.58B
-1.97%3.22B
13.06%3.22B
10.39%3.09B
6.10%3.05B
-25.22%11.81B
-32.45%3.29B
-14.96%2.85B
-45.06%2.8B
15.83%2.87B
Cost of revenue
16.37%1.82B
-4.37%517M
37.32%436.4M
36.28%404.9M
12.99%457.5M
-35.98%1.56B
-44.98%540.6M
-29.88%317.8M
-57.17%297.1M
31.46%404.9M
Gross profit
6.49%11.3B
1.51%2.92B
11.76%2.93B
7.54%2.75B
5.64%2.7B
-22.16%10.61B
-27.60%2.87B
-12.71%2.62B
-42.40%2.56B
15.29%2.56B
Operating expense
25.80%7.07B
12.81%1.91B
22.99%1.72B
38.58%1.74B
33.62%1.7B
21.10%5.62B
32.43%1.7B
21.03%1.39B
14.18%1.25B
14.95%1.27B
Selling and administrative expenses
24.36%2.63B
11.69%737.7M
21.05%640.5M
36.89%652M
33.58%601.1M
15.95%2.12B
18.03%660.5M
18.90%529.1M
14.85%476.3M
10.95%450M
Research and development costs
23.56%4.44B
12.86%1.18B
18.00%1.08B
36.64%1.09B
30.50%1.1B
25.61%3.59B
41.42%1.04B
36.96%911.3M
11.22%794.3M
13.58%843.8M
Other operating expenses
97.66%-2.1M
92.42%-500K
98.91%-500K
96.55%-600K
97.52%-500K
-97.15%-89.9M
58.23%-6.6M
-208.81%-45.7M
44.41%-17.4M
50.12%-20.2M
Operating profit
-15.23%4.23B
-14.78%1B
-1.04%1.21B
-22.22%1.02B
-22.06%1B
-44.48%4.99B
-56.22%1.18B
-33.75%1.22B
-60.96%1.31B
15.63%1.29B
Net non-operating interest income expense
319.96%422.9M
145.57%130.4M
319.93%115.9M
558.28%99.4M
1,475.51%77.2M
975.65%100.7M
67.51%53.1M
294.37%27.6M
204.86%15.1M
133.56%4.9M
Non-operating interest income
209.74%495.9M
110.92%148.7M
211.66%133.7M
319.50%118.3M
414.59%95.2M
249.56%160.1M
--70.5M
--42.9M
--28.2M
--18.5M
Non-operating interest expense
22.90%73M
5.17%18.3M
16.34%17.8M
44.27%18.9M
32.35%18M
3.66%59.4M
23.40%17.4M
7.75%15.3M
-9.03%13.1M
-6.85%13.6M
Other net income (expense)
-93.64%-456.8M
-84.92%14.3M
-183.60%-216.1M
90.80%-33M
3.65%-222M
-168.88%-235.9M
143.89%94.8M
1,676.22%258.5M
-185.43%-358.8M
-248.74%-230.4M
Gain on sale of security
-2,510.58%-250.7M
-65.50%45.2M
-139.44%-100.3M
81.12%-30.9M
22.02%-164.7M
-97.31%10.4M
--131M
--254.3M
---163.7M
---211.2M
Special income (charges)
27.05%-186.1M
0.00%-30M
---100M
--0
-99.64%-56.1M
-431.46%-255.1M
37.50%-30M
--0
---197M
---28.1M
-Less：Restructuring and merger&acquisition
-27.05%186.1M
0.00%30M
--100M
--0
99.64%56.1M
431.46%255.1M
-37.50%30M
--0
--197M
--28.1M
Other non- operating income (expenses)
-327.27%-20M
85.48%-900K
-476.19%-15.8M
-210.53%-2.1M
-113.48%-1.2M
120.00%8.8M
98.88%-6.2M
125.61%4.2M
-99.55%1.9M
-94.25%8.9M
Income before tax
-13.57%4.2B
-13.37%1.15B
-26.43%1.11B
12.43%1.08B
-19.14%858M
-47.90%4.86B
-47.08%1.32B
-16.89%1.51B
-74.33%963.2M
-15.32%1.06B
Income tax
-52.79%245.7M
-109.40%-12M
-46.93%103M
3.06%114.5M
-54.11%40.2M
-58.38%520.4M
-53.50%127.6M
5.26%194.1M
-83.01%111.1M
-36.43%87.6M
Net income
-8.87%3.95B
-3.13%1.16B
-23.40%1.01B
13.65%968.4M
-15.99%817.8M
-46.28%4.34B
-46.29%1.2B
-19.39%1.32B
-72.50%852.1M
-12.71%973.5M
Net income continuous Operations
-8.87%3.95B
-3.13%1.16B
-23.40%1.01B
13.65%968.4M
-15.99%817.8M
-46.28%4.34B
-46.29%1.2B
-19.39%1.32B
-72.50%852.1M
-12.71%973.5M
Minority interest income
Net income attributable to the parent company
-8.87%3.95B
-3.13%1.16B
-23.40%1.01B
13.65%968.4M
-15.99%817.8M
-46.28%4.34B
-46.29%1.2B
-19.39%1.32B
-72.50%852.1M
-12.71%973.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-8.87%3.95B
-3.13%1.16B
-23.40%1.01B
13.65%968.4M
-15.99%817.8M
-46.28%4.34B
-46.29%1.2B
-19.39%1.32B
-72.50%852.1M
-12.71%973.5M
Basic earnings per share
-8.54%37.05
-2.77%10.88
-22.99%9.48
14.56%9.05
-16.23%7.64
-46.98%40.51
-46.69%11.19
-19.91%12.31
-73.23%7.9
-13.80%9.12
Diluted earnings per share
-9.03%34.77
-2.95%10.19
-23.76%8.89
13.79%8.5
-16.72%7.17
-46.89%38.22
-46.67%10.5
-18.63%11.66
-73.29%7.47
-14.67%8.61
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 7.76%13.12B0.58%3.43B14.53%3.36B10.53%3.16B6.64%3.16B-24.26%12.17B-31.05%3.41B-14.96%2.94B-44.40%2.86B17.26%2.97B
Operating revenue 6.55%12.58B-1.97%3.22B13.06%3.22B10.39%3.09B6.10%3.05B-25.22%11.81B-32.45%3.29B-14.96%2.85B-45.06%2.8B15.83%2.87B
Cost of revenue 16.37%1.82B-4.37%517M37.32%436.4M36.28%404.9M12.99%457.5M-35.98%1.56B-44.98%540.6M-29.88%317.8M-57.17%297.1M31.46%404.9M
Gross profit 6.49%11.3B1.51%2.92B11.76%2.93B7.54%2.75B5.64%2.7B-22.16%10.61B-27.60%2.87B-12.71%2.62B-42.40%2.56B15.29%2.56B
Operating expense 25.80%7.07B12.81%1.91B22.99%1.72B38.58%1.74B33.62%1.7B21.10%5.62B32.43%1.7B21.03%1.39B14.18%1.25B14.95%1.27B
Selling and administrative expenses 24.36%2.63B11.69%737.7M21.05%640.5M36.89%652M33.58%601.1M15.95%2.12B18.03%660.5M18.90%529.1M14.85%476.3M10.95%450M
Research and development costs 23.56%4.44B12.86%1.18B18.00%1.08B36.64%1.09B30.50%1.1B25.61%3.59B41.42%1.04B36.96%911.3M11.22%794.3M13.58%843.8M
Other operating expenses 97.66%-2.1M92.42%-500K98.91%-500K96.55%-600K97.52%-500K-97.15%-89.9M58.23%-6.6M-208.81%-45.7M44.41%-17.4M50.12%-20.2M
Operating profit -15.23%4.23B-14.78%1B-1.04%1.21B-22.22%1.02B-22.06%1B-44.48%4.99B-56.22%1.18B-33.75%1.22B-60.96%1.31B15.63%1.29B
Net non-operating interest income expense 319.96%422.9M145.57%130.4M319.93%115.9M558.28%99.4M1,475.51%77.2M975.65%100.7M67.51%53.1M294.37%27.6M204.86%15.1M133.56%4.9M
Non-operating interest income 209.74%495.9M110.92%148.7M211.66%133.7M319.50%118.3M414.59%95.2M249.56%160.1M--70.5M--42.9M--28.2M--18.5M
Non-operating interest expense 22.90%73M5.17%18.3M16.34%17.8M44.27%18.9M32.35%18M3.66%59.4M23.40%17.4M7.75%15.3M-9.03%13.1M-6.85%13.6M
Other net income (expense) -93.64%-456.8M-84.92%14.3M-183.60%-216.1M90.80%-33M3.65%-222M-168.88%-235.9M143.89%94.8M1,676.22%258.5M-185.43%-358.8M-248.74%-230.4M
Gain on sale of security -2,510.58%-250.7M-65.50%45.2M-139.44%-100.3M81.12%-30.9M22.02%-164.7M-97.31%10.4M--131M--254.3M---163.7M---211.2M
Special income (charges) 27.05%-186.1M0.00%-30M---100M--0-99.64%-56.1M-431.46%-255.1M37.50%-30M--0---197M---28.1M
-Less：Restructuring and merger&acquisition -27.05%186.1M0.00%30M--100M--099.64%56.1M431.46%255.1M-37.50%30M--0--197M--28.1M
Other non- operating income (expenses) -327.27%-20M85.48%-900K-476.19%-15.8M-210.53%-2.1M-113.48%-1.2M120.00%8.8M98.88%-6.2M125.61%4.2M-99.55%1.9M-94.25%8.9M
Income before tax -13.57%4.2B-13.37%1.15B-26.43%1.11B12.43%1.08B-19.14%858M-47.90%4.86B-47.08%1.32B-16.89%1.51B-74.33%963.2M-15.32%1.06B
Income tax -52.79%245.7M-109.40%-12M-46.93%103M3.06%114.5M-54.11%40.2M-58.38%520.4M-53.50%127.6M5.26%194.1M-83.01%111.1M-36.43%87.6M
Net income -8.87%3.95B-3.13%1.16B-23.40%1.01B13.65%968.4M-15.99%817.8M-46.28%4.34B-46.29%1.2B-19.39%1.32B-72.50%852.1M-12.71%973.5M
Net income continuous Operations -8.87%3.95B-3.13%1.16B-23.40%1.01B13.65%968.4M-15.99%817.8M-46.28%4.34B-46.29%1.2B-19.39%1.32B-72.50%852.1M-12.71%973.5M
Minority interest income
Net income attributable to the parent company -8.87%3.95B-3.13%1.16B-23.40%1.01B13.65%968.4M-15.99%817.8M-46.28%4.34B-46.29%1.2B-19.39%1.32B-72.50%852.1M-12.71%973.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -8.87%3.95B-3.13%1.16B-23.40%1.01B13.65%968.4M-15.99%817.8M-46.28%4.34B-46.29%1.2B-19.39%1.32B-72.50%852.1M-12.71%973.5M
Basic earnings per share -8.54%37.05-2.77%10.88-22.99%9.4814.56%9.05-16.23%7.64-46.98%40.51-46.69%11.19-19.91%12.31-73.23%7.9-13.80%9.12
Diluted earnings per share -9.03%34.77-2.95%10.19-23.76%8.8913.79%8.5-16.72%7.17-46.89%38.22-46.67%10.5-18.63%11.66-73.29%7.47-14.67%8.61
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg